Oligonucleotide API Market - Top Companies and Manufacturers

Companies Dominating the Oligonucleotide API Landscape

Ionis Pharmaceuticals, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Jazz Pharmaceuticals plc
BIOGEN INC.
Sarepta Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Corden Pharma International GmbH
Nitto Denko Avecia, Inc.
Merck KGaA
Ajinomoto Co., Inc.
Kaneka Eurogentec S.A.

Browse Key Market Insights with Data Illustration:

Oligonucleotide API Market Size, Growth Trends 2037

In the News

Ionis Pharmaceuticals, Inc. in collaboration with Biogen Inc., has announced the results of the investigation of the use of antisense oligonucleotide (ASO) for people with C9orf72-associated amyotrophic lateral sclerosis (ALS).
Jazz Pharmaceuticals plc has announced that its Zepzelca (Lurbinectedin) has been approved by the U.S. Food and Drug Administration(FDA), for treating adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of oligonucleotide API is evaluated at USD 2.79 billion.

The oligonucleotide API market size was over USD 2.4 billion in 2024 and is poised to exceed USD 8 billion by 2037, growing at over 9.7% CAGR during the forecast period i.e., between 2025-2037. Globally rising prevalence of cancer and neurodegenerative diseases, growth in percentage of API manufacturing facilities, and growing expenditures on healthcare throughout the world will boost the market growth.

North America industry is estimated to hold largest revenue share of 36% by 2037, attributed majorly to increased healthcare spending, along with enhanced healthcare facilities in the region.

The major players in the market are Ionis Pharmaceuticals, Inc, .Jazz Pharmaceuticals plc, BIOGEN INC., Sarepta Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Corden Pharma International GmbH, Nitto Denko Avecia, Inc., Merck KGaA, Ajinomoto Co., Inc., Kaneka Eurogentec S.A.

Oligonucleotide API Market - Top Companies and Manufacturers

Companies Dominating the Oligonucleotide API Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the oligonucleotide API market?

Why is the oligonucleotide API sector gaining traction in near future?

Which region accounted for the largest oligonucleotide API industry share?

Who are the major oligonucleotide API players?